3rd Quarter - Report

TIMMONS AND COMPANY, INC. for TEVA PHARMACEUTICALS USA INC

Firm
Client
Income
$100,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (No Activity) Aug 11, 2008 $100,000 Replaced
3rd Quarter - Report (this page) Oct 9, 2008 $100,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

S. 28 - To amend title XVIII of the Social Security Act to require the use of generic drugs under the Medicare part D prescription drug program when available unless the brand name drug is determined to be medically necessary. S. 1505 - Affordable Biologics for Consumers Act. S. 1695 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. S. 242 - Pharmaceutical Market Access and Drug Safety Act of 2007. S. 251 - Pharmaceutical Market Access Act of 2007. S. 1082 - Prescription Drug User Fee Amendments of 2007. H.R. 2900 - Food and Drug Administration Amendments Act of 2007. H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act. H.R. 1038 - Access to Life-Saving Medicine Act. H.R. 5629 - Pathway for Biosimilars Act H.R. 3610 - Food and Drug Import Safety Act of 2007 H.R. 3624 - Consumer Food Safety Act of 2007

LobbyistCovered position, as disclosed
MICHAEL J BATES —
MICHELLE BRIGHT —
ERIN GRAEFE DORTON —
BRYCE L HARLOW —
GINGER LOPER —
MARTIN PAONE New Secretary for the Majority - US Senate
DANIEL SHAPIRO —
WILLIAM E TIMMONS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1695 (110th), S. 28 (110th), S. 242 (110th), H.R. 3610 (110th), S. 1082 (110th), S. 251 (110th), H.R. 3624 (110th), H.R. 5629 (110th), H.R. 1038 (110th), H.R. 1956 (110th), H.R. 2900 (110th), S. 1505 (110th)

Medicare/Medicaid MMM

H.R. 6331 - Medicare Improvements for Patients and Providers Act of 2008

LobbyistCovered position, as disclosed
MICHAEL J BATES —
MICHELLE BRIGHT —
ERIN GRAEFE DORTON —
BRYCE L HARLOW —
GINGER LOPER —
MARTIN PAONE New Secretary for the Majority - US Senate
DANIEL SHAPIRO —
WILLIAM E TIMMONS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6331 (110th)

Copyright/Patent/Trademark CPT

S. 25 - To amend the Federal Food, Drug, and Cosmetic Act to establish requirements for certain petitions submitted to the Food and Drug Administration, and for other purposes. S. 1145 - Patent Reform Act of 2007 H.R. 1908 - Patent Reform Act of 2007 H.R. 1432 - Preserve Access to Affordable Generics Act S. 3600 - Patent Reform Act of 2008

LobbyistCovered position, as disclosed
MICHAEL J BATES —
MICHELLE BRIGHT —
ERIN GRAEFE DORTON —
BRYCE L HARLOW —
GINGER LOPER —
MARTIN PAONE New Secretary for the Majority - US Senate
DANIEL SHAPIRO —
WILLIAM E TIMMONS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 25 (110th), S. 3600 (110th), S. 1145 (110th), H.R. 1432 (110th), H.R. 1908 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.